Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
McKinsey
Express Scripts
Medtronic
Boehringer Ingelheim

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

Litigation Details for Bayer Healthcare AG v. Teva Pharmaceuticals U.S.A., Inc. (D. Del. 2007)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Bayer Healthcare AG v. Teva Pharmaceuticals U.S.A., Inc. (D. Del. 2007)

Docket   Start Trial Date Filed 2007-04-05
Court District Court, D. Delaware Date Terminated 2008-05-19
Cause 35:271 Patent Infringement Assigned To Sue Lewis Robinson
Jury Demand None Referred To
Parties BAYER HEALTHCARE AG; BAYER PHARMACEUTICALS CORPORATION; TEVA PHARMACEUTICALS U.S.A., INC.
Patents 4,990,517; 5,607,942
Attorneys Anne Shea Gaza; Ashley Blake Stitzer; Frederick L. Cottrell , III; Richard D. Kirk
Link to Docket External link to docket
Small Molecule Drugs cited in Bayer Healthcare AG v. Teva Pharmaceuticals U.S.A., Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Bayer Healthcare AG v. Teva Pharmaceuticals U.S.A., Inc. (D. Del. 2007)

Date Filed Document No. Description Snippet Link To Document
2007-04-05 1 Complaint forth iierein. 7. United States Patent No. 4,990,517 (“the ’517 patent”), entitled “7-(1~ Pyrrolidinyl…expiration dates of United States Patent l\io,. 4,990,517 and United States Patent No. 5,607,942; (b) A preliminary… United States Patent nn Petersen et al. Filed 04/05/2007 t Page 2 Of 60 4,990,517 sea s, 1991 [tt… sTA'rES PATENT AND mDEMARK orr-acs CERTIFICATE OF CORRECTION PATENTNO. 2 4,990,517 DATED : February…TRADEMARK nance CERTIFICATE OF CORRECTION PATENT NO` :4,990,517 P;tgc 'l ol" 2 DATED ; Febrcary External link to document
2007-04-05 4 Patent/Trademark Report to Commissioner the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 4,990,517; 5,607,942; (els) (… OF PATENT OR TRADEMARK TRADEMARK NO. OR TRADEMARK 1 4,990,517 …Pharmaceuticals Corporation PATENT OR DATE OF PATENT … G Other Pleading PATENT OR DATE OF PATENT …REPORT ON THE TO: Director of the U.S. Patent and Trademark Office FILING External link to document
2007-04-24 7 Answer to Complaint States Patent No. 4,990,517 (“the ‘5 17 patent”) issued on February 5, 1991 and that the ‘517 patent bears…drug product before the expiration of U.S. Patents 4,990,517 and 5,607,942. Teva USA denies the remaining…States Patent No. 5,607,942 (“the ‘942 patent”) issued on March 4, 1997 and that the ‘942 patent bears …USA admits this is an action for patent inningement under the patent laws of the United States, Title …Healthcare AG (“BHC”) owns both the ‘5 17 patent and the ‘942 patent, and Teva USA denies the remaining allegations External link to document
2007-04-27 8 Motion to Consolidate Cases U,S, patents owned by BHC, U.S‘ l~"atent Nosr 4,990,5}7 (“the ’Sli’ patent“) and 5,607,942 (“the…234-SLR and Case No,. O`Y~IQS»SLR are actions for patent infringement under the I"iatch»Waxman Act;…the ’942 patent”), based on Teva’s filing of Abbreviated Nevv Drug Applications seeking to sell drug products… claims that the pertinent claims of these two patents are invalid and/or not infringed; 4, There Wiii… 2007 19 May 2008 1:07-cv-00195 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Harvard Business School
Mallinckrodt
Colorcon
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.